Denosumab 120mg/1ml solution for injection pre-filled syringes
NHS hospitals in England used £16,254,946 of indicative cost of Denosumab 120mg/1ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 21.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Denosumab 120mg/1ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Denosumab 120mg/1ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £945,383 |
| Univ Hpl B/Ham Nhs Foundation Trust | £834,763 |
| Barts Health Nhs Trust | £561,776 |
| Royal Surrey County Hosp Nhs Found Trust | £534,818 |
| Hull And East Yorkshire Hpls Nhs Trust | £497,325 |
| Shrewsbury & Telford Hospital Nhs Trust | £460,452 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £455,494 |
| Univ Hpls Bristol Nhs Foundation Trust | £440,621 |
| Barkinghavering & Redbridge Hpls Trst | £394,452 |
| The Christie Nhs Foundation Trust | £376,170 |
The primary-care picture
Denosumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Denosumab medicine page.